Global Injectable Drug Delivery Devices Market to capture a compound annual growth rate of 11.5% between 2018 and 2023. A wide range of devices fall under the category of injectable drug delivery devices including conventional syringes, needle-free injectors, and auto and pen injectors. Demand for such devices has continued to increase in recent years as they are being used to treatment of medical conditions that witnessing a high prevalence rate. By the year 2023, the global injectable drug delivery devices market is set to surpass a valuation of USD 31,900 Mn.
Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211
Advances in design and technology are allowing their usage in more complex delivery procedures. Introduction of next-generation devices with superior functional capabilities is having a positive impact on the global injectable drug delivery devices market. Others factor that can be linked with the market’s growth include increasing prevalence of chronic diseases, growing adoption of self-injectable devices, and rising FDA approvals.
Synopsis
This MRFR study includes a detailed analysis of the global injectable drug delivery devices market along with a five-year revenue projection that ends in 2023. As a part of market assessment, observation on different usage patterns (curative pattern and immunization), site of delivery (intramuscular, subcutaneous, intra dermal), product distribution channels (hospital & retail pharmacies and online platforms) and facility of use (hospitals and clinics and home care settings) is also made. The study also covers market dynamins such as drivers, trends, restrains and opportunities.
Companies Covered
Eisai Co., Ltd., Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Johnson & Johnson Services Inc., Mylan N.V., Novartis AG, Novo Nordisk, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and Inovio Pharmaceuticals Inc.The report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report.
Research Methodology
MRFR uses a set of cutting-edge research methods to provide consolidated reports rife with pertinent information and highly accurate assessments. Primary and secondary sources of information are carefully balanced for data authentication. Primary sources largely include interviews conducted with top-level executives. Meanwhile, secondary sources include authenticated databases, industry-specific journals, white papers, company annual reports and other public sources to ensure transparency. For market size estimation and validation, MRFR employs both top-down and bottom-up approaches for accuracy. All raw data is condensed into key data regarding the market and combined with pertinent observations from data analysts before report delivery.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment